logo Sykehusinnkjøp

New joint Nordic tendering procedures published

Norway, Iceland and Denmark are publishing a number of new joint Nordic tendering procedures, this time with the environment as one of three important criteria.

Publisert 09.06.2021

​In April 2019 Denmark, Norway and Iceland published the first joint Nordic tendering procedures​. At that time, we only evaluated tenders on price.

This time, price and security of supply are important criteria in our evaluation of which suppliers will be awarded the contract. Furthermore, a new third criterion is the environment.

Supply-c​ritical medicines

The joint Nordic tendering procedures include medicines in what we refer to as phases 5 and 6 of the medicine lifecycle. These are medicines that are potentially supply-critical or for which there is a de facto monopoly.

Specifically, the tendering procedures include the following medicines:

  • Ampicillin
  • Anagrelide
  • Ceftazidime
  • Ceftriaxone
  • Cefuroxime
  • Ciprofloxacin
  • Gentamicin
  • Meropenem
  • Methotrexate
  • Metronidazole
  • Ondansetrone
  • Paracetamol
  • Vancomycin

The procurement period for the tendering procedures will run from 1 April 2022 to 1 March 2024, with option for extension.

Read more: We invite suppliers to dialogue on joint Nordic tendering procedures